Brexit Means…Perplexity – Just Like in Chess

Brexit Means…Perplexity – Just Like in Chess By Victor Hill Brexit Means…Perplexity – Just Like in Chess The European politicians who perpetually nudge the United Kingdom to get on with it (that is, to trigger Article 50 and to set out, point-by-point, the definitive post-Brexit blueprint) are like junior chess players who huff and puff because their opponent spends too much time making his first move. They can't understand that considered meditation is itself a tactic in chess – discombobulate your opponent in the early game by pondering which pawn to move forward (one or two squares?) and you gain a psychological advantage. But the final plan will only become clear in the end-game. To be fair to the Euro-moaners, complaint and indignation is itself a negotiation tactic. (Though one that Mrs May and her team should blithely ignore). It is designed to disquiet the opponent by engendering self-doubt about their purposefulness (which, in chess, as in life, is to win)… Click Here To Read The Full Story The Master Investor Market Report The FTSE 100 closed the day at 6,776.95, a decrease of 81.75 points. The FTSE 250 fell 298.94 points to finish at 17,894.19. The FTSE All Share dropped 46.68 points to finish at 3,701.38. The FTSE AIM All Share ended the day at 805.39, down by 3.48 points. Pub operator JD Wetherspoons (JDW) said that it had booked revenues of £1.59 billion for the year ended 24th July, a 5.4% improvement over the previous 12 months. Profits before tax increased by 3.6% to £80.6 million despite pressure being placed on margins by the introduction of the government's "living wage" which significantly raised the largest element of Wetherspoon's cost base. Shares in the business climbed 2.44% to 946.50p.    Don't miss our September issue! Click HERE to read. Dechra Pharmaceuticals (DPH) has had its latest generic antibiotic approved for sale in the US by the Food and Drug Administration. The product is part of the development portfolio that the compay received following its recent takeover of Putney and represents its first entry in the substantial antbiotics market. Shares in Dechra Pharmaceuticals fell 20p to 1,334p. Hospitality group Richoux (RIC) was also heavily impacted by the introduction of the living wage and swung to a loss of £0.58 million for the 28 weeks ended 10th July. Turnover did increase by 5.7% to £7.08 million as the company opened three new sites. Management remain hopeful about the future and will continue to open new outlets as opportunities present themselves. The shares closed at 21.50p, down by 4.44%. Monday's news today Abcam (ABC) will release final results. Quote of the day "The more laws, the less justice." - Cicero Latest Stories Oh Mr Solger, What shall I do? By John Cornford Those who followed me into Solomon Gold, at 3p in March and at 7p two weeks ago, have a short term dilemma. What to do now that the shares have briefly touched 14p and are currently 10p (a potential chart bouncing level)… Click Here To Read The Full Story Time to Sell the European Yield Madness By Filipe R Costa At a time when investors need to pay European corporations for the privilege of lending them money, the degree of financial madness should have reached level 100. Governments around the world excused themselves from leading their own sluggish economies towards healthier states… Click Here To Read The Full Story The funds trying to do no evil By Nick Sudbury It is hard to think of an area that divides opinion more strongly than Socially Responsible Investing (SRI). Those who believe in it think that companies that follow these principles will outperform and by actively engaging with those that don't they can change the world for the better… Click Here To Read The Full Story Chart of the Day: GW Pharmaceuticals By Zak Mir Gaps through the 50 day moving average are normally great momentum indicators. This is especially the case when a stock or market is towards the lower end of the range. In the case of GW Pharma we have a mid-range version of the genre... Click Here To Read The Full Story India's Fintech Revolution By Samuel Rae It was bound to happen – and now it has. India's love affair with technology and e-commerce has spawned an explosion in "fintech". We can define fintech as digital technology businesses that compete against (and disrupt) – or sometimes support – the activities of established financial institutions… Click Here To Read The Full Story Join the movement on social media: Copyright 2016 Master Investor Ltd, All rights reserved. You are receiving this email because you opted in at our website. If a Daily Bulletin is too frequent, why not opt in to our once weekly mailing list for a round up of the week's news straight to your inbox. Once Weekly Round-Up Our mailing address is: Suite 88, 22 Notting Hill Gate, London W11 3JE Master Investor is a trading name of Master Investor Limited. Material contained within Master Investor Magazine and its website is for general information purposes only and is not intended to be relied upon by individual readers in making (or refraining from making) any specific investment decisions. Master Investor Ltd does not accept any liability for any losses suffered by any user as a result of any such decision.

This email was sent to educationspeculator.davinci@blogger.com why did I get this?    unsubscribe from this list    update subscription preferences Master Investor Ltd · Suite 88 · 22 Notting Hill Gate · London, London W11 3JE · United Kingdom